181696-12-8

Basic information

• Product Name: 4-(5-methyl-4-phenylisoxazol-3-yl)benzenesulfonamide
• Synonyms: 4-(5-methyl-4-phenylisoxazol-3-yl)benzenesulfonamide;Parecoxib Impurity 11
• CAS NO: 181696-12-8
• Molecular Formula: C₁₆H₁₄N₂O₃S
• Molecular Weight: 314.35896
• EINECS: -0
• Mol File: 181696-12-8.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-(5-methyl-4-phenylisoxazol-3-yl)benzenesulfonamide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(5-methyl-4-phenylisoxazol-3-yl)benzenesulfonamide(181696-12-8)
• EPA Substance Registry System: 4-(5-methyl-4-phenylisoxazol-3-yl)benzenesulfonamide(181696-12-8)

Safety Data

• Hazardous Substances Data: 181696-12-8(Hazardous Substances Data)

Usage

General Description

The chemical compound 4-(5-methyl-4-phenylisoxazol-3-yl)benzenesulfonamide is a sulfonamide derivative with a unique molecular structure. It contains a sulfonamide group attached to a benzene ring, which in turn is linked to an isoxazole ring with a methyl and phenyl substituent. 4-(5-methyl-4-phenylisoxazol-3-yl)benzenesulfonamide has potential use in pharmaceuticals or agrochemicals due to its diverse structural features and potential biological activities. Further research into its properties and applications may reveal its potential for use in medicinal and agricultural purposes.

Upstream product

• 37928-17-9 5-methyl-3,4-diphenyl isoxazole 
• 701-34-8 4-bromo-benzenesulfonic acid amide 
• 2001-29-8 1-(4-bromophenyl)-2-phenyl-ethan-1-one 
• 181697-18-7 1-(4-bromophenyl)-2-phenyl-ethan-1-one oxime 
• 181697-19-8 4-[5-methyl-4-phenylisoxazol-3-yl]bromobenzene 
• 219679-74-0 3-methyl-4-(4-methylthiophenyl)-5-phenylisoxazole 
• 21262-87-3 3-(4-bromophenyl)-5-methyl-1,2-oxazole 
• 98-80-6 phenylboronic acid 
• 1122-91-4 4-bromo-benzaldehyde 

Relevant articles and documents

Bisaryl substituted isoxazole compound as well as preparation method and application thereof

The invention discloses a diaryl substituted isoxazole compound as well as a preparation method and a purpose thereof, particularly reports a parecoxib sodium impurity P, namely N-{4-[(5-methyl-4-phenylisoxazole-3-yl)phenyl]sulfonyl}propionamide, as well

Preparation method for impurity of parecoxib sodium

The invention belongs to the technical field of medicinal chemistry, and in particular relates to a preparation method for an impurity of parecoxib sodium. A synthetic method of the compound PRN073-11is never mentioned in the prior art, a very small amoun

LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER

The present invention provides a large conductance calcium-activated K channel opener comprising a compound of the formula (I): wherein R1 and R3 are each sulfonamide, carbamoyl, acyl, amino, and the like, m and n are each 0 to 2, R2 and R4 are each cyano, nitro, hydroxyl, an alkoxy, a halogen, or an alkyl, Ring A is benzene or a heterocyclic ring, Ring B is benzene, a heterocyclic ring, a cycloalkane etc, and Ring Q is pyrazole or isoxazole, or a pharmaceutically acceptable salt thereof as an active ingredient.